ArticleEClinicalMedicine2025

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study.

Xin-Xin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.